The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
Vertex Pharmaceuticals Inc. (VRTX) has secured FDA approval for Suzetrigine, an oral, non-opioid, highly selective NaV1.8 pain signal ...
The Food and Drug Administration approved a new type of nonopioid painkiller, Journaxv, or suzetrigine, drugmaker Vertex ...
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
Neuropathy, a debilitating condition affecting millions worldwide, can significantly impair daily life and well-being. Traditional treatments often fall short, offering temporary relief at best while ...
This increase in blood pressure was similar to that seen with NSAIDs, suggesting that long-term use of paracetamol might ...
Ginger’s anti-inflammatory and antioxidant properties can help with acne reduction. Check out how to make and consume ginger ...
“Non-steroidal anti-inflammatory drugs, or NSAIDs, like ibuprofen, and naproxen and Motrin, treat actual inflammation,” Brown explained. “So they’re blocking an enzyme to prevent any ongoing ...